Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yaron Naos currently holds 225,817 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yaron Naos has been a net neutral trader of PLX stock. They have purchased $0 and sold $0 worth of shares.
Yaron Naos's most recent insider trade was on Sep 3, 2025, when they sold 25,000 shares at $0.00 per share.
Yaron Naos serves as Executive at Protalix BioTherapeutics, Inc. (PLX). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Yaron Naos holds the position of Executive at Protalix BioTherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Yaron Naos has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Yaron Naos was on Sep 3, 2025, when they purchased $0 worth of PLX shares. This transaction involved 25,000 shares at N/A per share.
Yaron Naos currently owns 225,817 shares of Protalix BioTherapeutics, Inc. (PLX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yaron Naos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yaron Naos has 3 Form 4 filings on record as an insider at Protalix BioTherapeutics, Inc..
Set alerts for Yaron Naos and 40,000+ other insiders.